3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
7
Stomach Neoplasms
2
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Neutropenia
1
Neoplasm Metastasis
1
Gastric and Gastroesophageal Junction Adenocarcinoma
1
Esophageal Squamous Cell Carcinoma
1
EFS
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breast Neoplasms
1
Anal Cancer Metastatic
1
Advanced Solid Tumors
1
Advanced Colorectal Cancer
1
Adenocarcinoma Of Esophagus
1
Adenocarcinoma
1
Interventions
trifluridine tipiracil drug combination
1
reolysin
1
atezolizumab
1
Gemcitabine
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Anal Cancer Metastatic
×
trifluridine tipiracil drug combination
×
Clear all
NCT07280377
2026-05-19
GOBLET
Oncolytics Biotech
Phase 1/2
Active not recruiting
122 enrolled